Urology Times Newsletter

MEN’S HEALTH MONDAY

The case for transperineal prostate Bx vs. the transrectal approach

Reduced infection rate may drive increased use of the transperineal approach, according to Parth Patel, MD, Alex Belshoff, MD, PhD, and Gopal Gupta, MD.

Learn more

TP-Bx: The answer to rising infectious complications?

"A more standardized protocol that is office based, reliable, and reproducible as well as cost- and time-efficient is required to entice more urologists to abandon the TRUS-BX approach," writes J. Brantley Thrasher, MD.

Read his editorial

SURVEY

Is DRE still a relevant tool in the management of prostate cancer?

Urine Alkalinization for Kidney Stones

Tim Large, MD, describes how urine alkalinization reduced stone complexity, cost, morbidity and the burden of stone disease for a patient with a staghorn uric acid kidney stone that compromised almost the entire renal pelvis.

Watch the case study video now.